Cargando…
Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
Japan has reported a relatively small number of COVID-19 cases. Because not all infected persons receive diagnostic tests for COVID-19, the reported number must be lower than the actual number of infections. We assessed SARS-CoV-2 seroprevalence by analyzing >60,000 samples collected in Japan (To...
Autores principales: | Yamayoshi, Seiya, Iwatsuki-Horimoto, Kiyoko, Okuda, Moe, Ujie, Michiko, Yasuhara, Atsuhiro, Murakami, Jurika, Duong, Calvin, Hamabata, Taiki, Ito, Mutsumi, Chiba, Shiho, Kobayashi, Ryo, Takahashi, Satoshi, Mitamura, Keiko, Hagihara, Masao, Shibata, Akimichi, Uwamino, Yoshifumi, Hasegawa, Naoki, Ebina, Toshiaki, Izumi, Akihiko, Kato, Hideaki, Nakajima, Hideaki, Sugaya, Norio, Seki, Yuki, Iqbal, Asef, Kamimaki, Isamu, Yamazaki, Masahiko, Kawaoka, Yoshihiro, Furuse, Yuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622230/ https://www.ncbi.nlm.nih.gov/pubmed/36198306 http://dx.doi.org/10.3201/eid2811.221127 |
Ejemplares similares
-
Seroprevalence of SARS-CoV-2 antibodies in dogs and cats during the early and mid-pandemic periods in Japan
por: Yamayoshi, Seiya, et al.
Publicado: (2023) -
Anti-SARS CoV-2 IgG in COVID-19 Patients with Hematological Diseases: A Single-center, Retrospective Study in Japan
por: Fujii, Takayuki, et al.
Publicado: (2022) -
Evaluation of the fusion partner cell line SPYMEG for obtaining human
monoclonal antibodies against influenza B virus
por: SONI, Priyanka, et al.
Publicado: (2018) -
Differences among epitopes recognized by neutralizing antibodies induced by SARS-CoV-2 infection or COVID-19 vaccination
por: Yamamoto, Shinya, et al.
Publicado: (2023) -
Antibody titers against SARS-CoV-2 decline, but do not disappear for several months
por: Yamayoshi, Seiya, et al.
Publicado: (2021)